Iron deficiency from the standpoint of cardiac rehabilitation: novel therapeutic opportunities

Autor: Gabriella Malfatto, Anna Frisinghelli, Marco Ambrosetti, Maria Teresa La Rovere, Irene Motta, Bruno Passaretti, Marco Pavesi, Roberto Tramarin, Niccolò Dasseni, Pompilio Faggiano

Publikováno v: Monaldi Archives for Chest Disease, Vol 89, Iss 3 (2019)

Anemia is one of the most frequent comorbidities found in patients with coronary artery disease and chronic heart failure (CHF) who are being followed in cardiac rehabilitation facilities. The more frequent type of anemia is caused by iron deficiency

Externí odkaz: https://doaj.org/article/b6e897c9ed6b421fb99ac4d70bcfface

Serum uric acid and outcomes in patients with chronic heart failure through the whole spectrum of ejection fraction phenotypes: Analysis of the ESC-EORP Heart Failure Long-Term (HF LT) Registry

Autor: Roberto Ferrari, Luis Almenar-Bonet, Lars Lund, Andrea Cardona, Massimo F Piepoli, Andrew J.S. Coats, Aldo P. Maggioni, Giuseppe Ambrosio, Stefano Coiro, Cécile Laroche, Pentti Poder, Marisa Crespo Leiro, Anna Frisinghelli, Stefan D. Anker, Gerasimos Filippatos, David Bierge Valero

Publikováno v: EUROPEAN JOURNAL OF INTERNAL MEDICINE
r-IIS La Fe. Repositorio Institucional de Producción Científica del Instituto de Investigación Sanitaria La Fe
instname

Background: Retrospective analyses of clinical trials indicate that elevated serum uric acid (sUA) predicts poor outcome in heart failure (HF). Uric acid can contribute to inflammation and microvascular dysfunction, which may differently affect diffe

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07c4993692ea486540aaf0f69a12cb25
https://fundanet.iislafe.san.gva.es/publicaciones/ProdCientif/PublicacionFrw.aspx?id=14727

Secondary prevention advices after cardiovascular index event: From drug prescription to risk factors control in real world practice

Autor: Francesco Fattirolli, Luigi Esposito, Lucrezia Piccioli, Francesco Giallauria, Pompilio Faggiano, Rosaria Garrì, Laura Albricci, Maria Vittoria Silverii, Nicolò Dasseni, Anna Frisinghelli, Giuseppe D'Ambrosio

Publikováno v: Monaldi Archives for Chest Disease, Vol 89, Iss 2 (2019)

The present study aims at evaluating the achievement of blood pressure, lipid and blood glucose targets, healthy lifestyle changes and appropriate drug prescription/adherence in patients attending secondary prevention/CR ambulatory visit after index

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a869a9615c02e18ed0e5f3c4134c3a6c
https://doi.org/10.4081/monaldi.2019.1040

Regression or Reduction in Progression of Atherosclerosis, and Avoidance of Coronary Events, With Lovastatin in Patients With or at High Risk of Cardiovascular Disease

Autor: Antonio Mafrici, Anna Frisinghelli

Publikováno v: Clinical Drug Investigation. 27:591-604

HMG-CoA reductase inhibitors (statins) are the drugs of first choice for treating hypercholesterolaemia in order to prevent or slow the progression of coronary heart disease (CHD). Statins generally reduce the risk of CHD morbidity or mortality by ab

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::30980011d58b20029f2ed93af89282b2
https://doi.org/10.2165/00044011-200727090-00001

[Appropriateness of diagnostic tests in cardiovascular prevention: what can we skip?]

Autor: Antonella, Cherubini, Gian Francesco, Mureddu, Pier Luigi, Temporelli, Anna, Frisinghelli, Piero, Clavario, Francesca, Cesana, Francesco, Fattirolli

Publikováno v: Giornale italiano di cardiologia (2006). 15(4)

In recent years, a huge increase in the use of cardiac procedures, both invasive and non-invasive, was observed. Diagnostic tests, mainly non-invasive tests, are often prescribed inappropriately, in most cases replacing the clinical evaluation. The r

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=pmid________::30a84aad247fac91083a2745a3a9a6c9
https://pubmed.ncbi.nlm.nih.gov/24873815